Guidance for the governance of public-private collaborations in vaccine post-marketing settings in Europe-Reference-Cited by-同舟云学术

Guidance for the governance of public-private collaborations in vaccine post-marketing settings in Europe

Published:2019-05 Issue:25 Volume:37 Page:3278-3289
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Torcel-Pagnon Laurence,Bauchau Vincent,Mahy Patrick,Tin Tin Htar Myint,van der Sande Marianne,Mahé Cédric,Krause Tyra Grove,Charrat Anne,Simondon François,Kurz Xavier

Funder

Innovative Medicines Initiative

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference20 articles.

1. European Medicines Agency. Pandemic report and lessons learned. Outcome of the European Medicines Agency's activities during the 2009 (H1N1) flu pandemic. EMA/221017/2011. Available at: [accessed on: 15 May 2018].

2. Safety monitoring of Influenza A/H1N1 pandemic vaccines in EudraVigilance;Kurz;Vaccine,2011

3. Sturkenboom M, Bahri P, Chiucchiuini A, Grove Krause T, S. H, Khromava A, et al. Why we need more collaboration in Europe to enhance post-marketing surveillance of vaccines. Vaccine. 2018;Paper 1 in ADVANCE supplement.

4. ADVANCE. Available at: [accessed on: 20 June 2018].

5. The Innovative Medicines Initiative: an engine for regulatory science;Goldman;Nat Rev Drug Discov.,2015

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ethical implications of COVID-19 management—is freedom a desired aim, or a desired means to an end?;Frontiers in Public Health;2024-04-26

2. The Impact of Institutional Governance in Performance Enhancement of the Jordanian National Assembly Members;Lecture Notes in Networks and Systems;2024

3. Regulatory consideration and pathways for vaccine development;Advanced Vaccination Technologies for Infectious and Chronic Diseases;2024

4. Addressing conflicts of interest regarding the vaccine in infectious disease outbreaks based on good governance for health approach: a policy brief;BMC Health Services Research;2023-09-25

5. Development of medicines for rare diseases and inborn errors of metabolism: Toward novel public–private partnerships;Journal of Inherited Metabolic Disease;2023-04